Sub-Saharan Africa’s ‘exceptional’ progress against HIV – surveys

Organisation: Position: Deadline Date: Location:

National surveys in Zimbabwe, Malawi, and Zambia reveal exceptional progress against HIV, with decreasing rates of new infection, stable numbers of people living with HIV, and more than half of all those living with HIV showing viral suppression through use of antiretroviral medication.

For those on antiretroviral medication, viral suppression is close to 90%. Thirty-five years into the global HIV epidemic, these findings are a clear sign of progress and source of hope for the rest of the world.

These data are the first to emerge from the Population HIV Impact Assessment (PHIA) Project, a unique, multi-country initiative funded by the US President’s Emergency Plan for AIDS Relief (PEPFAR). The project deploys household surveys, which measure the reach and impact of HIV prevention, care and treatment programs in select countries. ICAP at Columbia University is implementing the PHIA Project in close collaboration with the US Centres for Disease Control and Prevention (CDC) and in partnership with ministries of health.

Importantly, the data positively demonstrate that the 90-90-90 global targets set forth by UNAIDS in 2014 are attainable, even in some of the poorest countries in the world. According to these ambitious targets for 2020, the goal is for 90% of people with HIV to be diagnosed, 90% of those diagnosed to receive HIV treatment, and 90% of those on treatment to be effectively treated and achieve suppression of their infection. This would translate to 73% of all HIV-positive people being virally suppressed. The data show that once diagnosed, individuals are accessing treatment, staying on treatment, and their viral load levels are suppressed to levels that maintain their health and dramatically decrease transmission to others.

“The effects of HIV have been far-reaching. But these outcomes affirm that global, country, and US-supported HIV efforts have been successful to date, and that strong progress is being made across the entire HIV continuum of care, including excellent durability of first line treatment regimens with high adherence to medications,” said Ambassador Deborah Birx, US Global AIDS coordinator.

The PHIA Project surveys describe national HIV epidemics by looking at HIV incidence (the rate of new infections), HIV prevalence (the percent of the population living with HIV), and the prevalence of viral load suppression (a measure of a well-controlled HIV infection), all through a nationally-representative sample of the population. Additional measures in the surveys look at the proportion of those with HIV who have been tested and who are on treatment.

The household surveys of approximately 80,000 adults and children in Zimbabwe, Malawi, and Zambia were conducted in 2016. Results show that the rate of new infections is less than 1% per year. HIV prevalence, at 10% to 14%, is similar to 2010 estimates, and more than half of all adults living with HIV have viral load suppression.

Compared to 2003 incidence estimates for the same three countries of between 1.3% and 1.5% per year, the current rate of new HIV infections has been cut in half during the past 13 years, when effective HIV treatment became available in sub-Saharan Africa largely through support from PEPFAR.

“The survey was designed to identify the rate of new infections at the national level, as well as to estimate the number of people living with HIV,” said Dr Jessica Justman, PHIA principal investigator and senior technical director at ICAP. “This information is critically important to determining future resource needs.”

Preliminary data analyses show that, as of 2016:
In Zimbabwe, among adults ages 15 to 64, HIV incidence is 0.45%; HIV prevalence is 14.6% (16.7% among females and 12.4% among males); 60.4% of all HIV-positive people are virally suppressed, and 86% of those on treatment are virally suppressed.
In Malawi, among adults ages 15 to 64, HIV incidence is 0.37%; HIV prevalence is 10.6% (12.8% among females and 8.2% among males); 67.6% of all HIV-positive people are virally suppressed, and 91% of those on treatment are virally suppressed.
In Zambia, among adults ages 15 to 59 years, HIV incidence is 0.66%; HIV prevalence is 12.3% (14.9% among females and 9.5% among males); 59.8% of all HIV-positive people are virally suppressed, and 89% of those on treatment are virally suppressed.

“The partnership with the ministries of health has been fundamental to the success of the surveys,” said Dr Shannon Hader, director of the division of global HIV and Tuberculosis at CDC. “This kind of information has not been available before and the ministries are eager to use the survey results to inform their policies and programmes.”

With high HIV prevalence estimates of 10% to14%, these three countries continue to bear a substantial HIV burden. Nonetheless, with prevalence stabilising and incidence falling, the PHIA survey results suggest that people living with HIV are living longer thanks to effective and accessible treatment.

“It is heartening to see the impressive viral suppression noted in the three countries among those on treatment,” said Dr Wafaa El-Sadr, global director of ICAP. “Viral suppression is critical for the well-being of people living with HIV and for preventing HIV transmission to others.”

The results from the first three PHIA surveys compel the global community to strengthen its efforts to reach those who have yet to receive an HIV test and to engage, support, and enable those who test HIV-positive to start and stay on effective treatment in order to achieve long-term viral suppression.

“Importantly, the PHIA surveys point to what still needs to be done, who we need to reach, and where we must focus our efforts, in order to build on these achievements,” Birx added. “The findings will guide an effective response to the epidemic.”

Columbia University’s Mailman School of Public Health material
Zimbabwe survey preliminary results
Malawi survey preliminary results
Zambia survey preliminary results


Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.